Use of fatty donor liver is associated with diminished early patient and graft survival.
about
Deceased donor risk factors influencing liver transplant outcomeRadiologic evaluation of nonalcoholic fatty liver diseaseIcam-1 upregulation in ethanol-induced Fatty murine livers promotes injury and sinusoidal leukocyte adherence after transplantation.The survival outcomes following liver transplantation (SOFT) score: validation with contemporaneous data and stratification of high-risk cohorts.Inhibition of inducible nitric oxide synthase prevents mitochondrial damage and improves survival of steatotic partial liver grafts.Intermittent ischaemia maintains function after ischaemia reperfusion in steatotic livers.Toll-like receptor 4 is a key mediator of murine steatotic liver warm ischemia/reperfusion injury.Expectations from imaging for pre-transplant evaluation of living donor liver transplantation.Hepatocyte apoptosis is enhanced after ischemia/reperfusion in the steatotic liver.Liver grafts from selected older donors do not have significantly more ischaemia reperfusion injury.Evaluation of hepatic steatosis in dogs with congenital portosystemic shunts using Oil Red O stainingHepatic steatosis is not always a contraindication for cadaveric liver transplantation.Correlation between liver volume, portal vascular anatomy, and hepatic perfusion in dogs with congenital portosystemic shunt before and after placement of ameroid constrictors.Does hepatic steatosis have an impact on the short term hepatic response after complete attenuation of congenital extrahepatic portosystemic shunts? A prospective study of 20 dogs.Successful transplantation of reduced-sized rat alcoholic fatty livers made possible by mobilization of host stem cells.Non-alcoholic fatty liver disease, non-alcoholic steatohepatitis and orthotopic liver transplantation.Decreased apoptosis in fatty livers submitted to subnormothermic machine-perfusion respect to cold storage.Ischemia-Reperfusion Injury and Ischemic-Type Biliary Lesions following Liver Transplantation.Clinical review of nonalcoholic steatohepatitis in liver surgery and transplantationMitochondrial uncoupling protein-2 mediates steatotic liver injury following ischemia/reperfusion.Comparative accuracy of CT, dual-echo MRI and MR spectroscopy for preoperative liver fat quantification in living related liver donors.Reduced inflammatory response and increased microcirculatory disturbances during hepatic ischemia-reperfusion injury in steatotic livers of ob/ob mice.Ischemia-reperfusion injury in rat steatotic liver is dependent on NFκB P65 activationNon-alcoholic fatty liver disease and liver transplantation: outcomes and advances.MMP-9 deficiency shelters endothelial PECAM-1 expression and enhances regeneration of steatotic livers after ischemia and reperfusion injury.What is critical for liver surgery and partial liver transplantation: size or quality?Grade of deceased donor liver macrovesicular steatosis impacts graft and recipient outcomes more than the Donor Risk Index.Perioperative nutritional therapy in liver transplantation.Overweight in liver transplant recipients.The use of the Papworth cocktail is detrimental to steatotic livers after ischemia-reperfusion injuryAnti-endotoxin monoclonal antibodies are protective against hepatic ischemia/reperfusion injury in steatotic mice.Fatty acid synthase blockade protects steatotic livers from warm ischemia reperfusion injury and transplantation.Donor liver histology--a valuable tool in graft selection.NLRP3 inflammasome induced liver graft injury through activation of telomere-independent RAP1/KC axis.Comparing morphometric, biochemical, and visual measurements of macrovesicular steatosis of liver.Hard clinical outcomes in patients with NAFLD.Nonalcoholic fatty liver disease following liver transplantation.Body mass index as a predictor of hepatic steatosis in living liver donors.8-pCPT-cGMP prevents mitochondrial depolarization and improves the outcome of steatotic partial liver transplantationImpact of Recipient and Donor Obesity Match on the Outcomes of Liver Transplantation: All Matches Are Not Perfect.
P2860
Q27003929-61687A1C-67EF-4C37-8FAA-4A26CFA6DA3DQ30436162-2892708D-D2ED-4D5D-A5D8-BF45664E636EQ30518813-9226A6F8-E97F-4988-8C54-CD762CAD9727Q30652056-60B30653-E629-4DC3-9F98-8031982FCFB8Q33671918-8F88ED73-4BAC-4ABA-87E0-AE47B900BF11Q33865021-F9BB199D-4DEB-4CE0-90BE-5CA25B20EEDDQ34121869-354CA9F2-E28D-43B0-B910-241CC85ADBB6Q34251813-2CE1028D-CC7A-4577-B376-DDEA992AFE38Q34609691-143F7226-E60F-4F92-97EF-8BAE7A43B980Q34625573-64AE87AF-6969-4B2D-9819-92F0609DB418Q34635995-13A7D17C-F429-4257-A44B-D1EFEA4945EEQ35010235-8BE53453-1E50-4BCC-A108-7C715ABBE8A8Q35145893-58A20E22-835E-446B-8FD0-1B7AC6CBBDB0Q35167111-4758C816-C635-4BD7-8D4E-E55D4D115332Q35709234-54B4E35C-2FEC-4A54-9799-D20327272686Q35745702-A8D8AC09-1525-4BA0-B329-F364E251FBE7Q35771439-37BE1CEB-3FE3-40FF-9FB1-ED1E6E8AE19FQ35864132-3197D280-E873-4626-A1BA-F02B67F79543Q36165357-97D99730-3654-406E-8880-5C6CB84D75C2Q36704140-351AAC34-782D-426C-94F0-6783F01A9A74Q36743255-62A7AB2F-471D-4F91-9ABF-B8EBA2680FA7Q36884033-97D333CF-76D8-492A-A967-F16503D4AFF9Q36910697-08B845DA-70DA-4B70-B0F7-96C2472800EAQ37439861-73D58F8D-04AE-4F07-91A9-2B1D2238B5ECQ37716860-9C9AE0CA-10FF-4731-900D-B2F2B0373808Q37777694-A2CC1B56-91E6-4F3E-A852-9962D50BA4DBQ37903388-83DBAEEE-F8E5-440D-AD90-406FDD78DD47Q38182848-69138150-CE64-4D46-9393-6C2E1CAAD5A5Q38191466-E9E2FB4E-9F51-4F90-88E1-3802DC8BD790Q38289090-A47A6295-E5FE-4CB2-AC5C-4F58134EA0CFQ38336737-45A0DCBB-8339-4C10-90BC-88F98E4E8F98Q38337815-39DF4602-53B6-4806-9279-9A7F860060C8Q38391099-ED8C846C-55D6-4DD6-87AB-6568C5EA4D99Q38853974-7327A002-CC8F-4FEB-9717-5D62BA717304Q39960383-9632F4D6-70F2-48E5-A5F5-4D6669BD0702Q40706265-FA6416B4-8680-4BDE-A43C-723A30427AA9Q40707333-EB8C9EE3-913D-41F4-BC74-638814A015FEQ40708465-F28EF226-BB07-41E9-ABF2-AF5722731862Q40955377-AB97CF8F-6037-4758-8B46-FA00EC7D0996Q41096265-0142F6FD-A306-455A-B188-62497D1F8BAC
P2860
Use of fatty donor liver is associated with diminished early patient and graft survival.
description
1996 nî lūn-bûn
@nan
1996年の論文
@ja
1996年学术文章
@wuu
1996年学术文章
@zh
1996年学术文章
@zh-cn
1996年学术文章
@zh-hans
1996年学术文章
@zh-my
1996年学术文章
@zh-sg
1996年學術文章
@yue
1996年學術文章
@zh-hant
name
Use of fatty donor liver is associated with diminished early patient and graft survival.
@en
Use of fatty donor liver is associated with diminished early patient and graft survival.
@nl
type
label
Use of fatty donor liver is associated with diminished early patient and graft survival.
@en
Use of fatty donor liver is associated with diminished early patient and graft survival.
@nl
prefLabel
Use of fatty donor liver is associated with diminished early patient and graft survival.
@en
Use of fatty donor liver is associated with diminished early patient and graft survival.
@nl
P2093
P1433
P1476
Use of fatty donor liver is associated with diminished early patient and graft survival.
@en
P2093
Marsman WA
Porayko MK
Rodriguez L
Wiesner RH
P304
P356
10.1097/00007890-199611150-00011
P577
1996-11-01T00:00:00Z